INTRODUCTION: Endometrial cancer (EC) is the most common gynecologic cancer in the United States. Racial disparities in the incidence and mortality of this cancer are apparent; black women are less likely to develop this malignancy, and yet are more likely to die when diagnosed. Racial differences of second primary cancer (SPC) have not been examined and are the goal of this study. METHODS: Using the National Cancer Institute's Surveillance, Epidemiology, and End Results database, SPC risk in white and black EC cases was compared to the general population and to women with other primary cancers. Standardized incidence ratios (SIRs) of SPC (overall and by tumor site) with 95% confidence intervals were calculated. Poisson regression was used to estimate the race-specific risk of SPC in EC cases treated with radiotherapy vs. non-irradiated cases. RESULTS: The analysis included 11,047 EC cases diagnosed between 1973 and 2007 that developed a SPC. Overall risk of SPC in white EC cases was significantly lower than the general population (SIR=0.85, 95% CI: 0.84, 0.87), but significantly higher in black EC cases (SIR=1.19, 95% CI: 1.08, 1.31). White EC cases treated with radiotherapy were more likely to develop SPC compared to non-irradiated cases (IRR=1.18, 95% CI: 1.14, 1.23). CONCLUSIONS: This is the first analysis of race-specific SPC risk in EC cases and it suggests differences between white and black cases. Although exploratory, these data provide important clues about the etiology of SPC in patients with EC. This analysis also highlights the need for careful monitoring following diagnosis and treatment of EC.
INTRODUCTION:Endometrial cancer (EC) is the most common gynecologic cancer in the United States. Racial disparities in the incidence and mortality of this cancer are apparent; black women are less likely to develop this malignancy, and yet are more likely to die when diagnosed. Racial differences of second primary cancer (SPC) have not been examined and are the goal of this study. METHODS: Using the National Cancer Institute's Surveillance, Epidemiology, and End Results database, SPC risk in white and black EC cases was compared to the general population and to women with other primary cancers. Standardized incidence ratios (SIRs) of SPC (overall and by tumor site) with 95% confidence intervals were calculated. Poisson regression was used to estimate the race-specific risk of SPC in EC cases treated with radiotherapy vs. non-irradiated cases. RESULTS: The analysis included 11,047 EC cases diagnosed between 1973 and 2007 that developed a SPC. Overall risk of SPC in white EC cases was significantly lower than the general population (SIR=0.85, 95% CI: 0.84, 0.87), but significantly higher in black EC cases (SIR=1.19, 95% CI: 1.08, 1.31). White EC cases treated with radiotherapy were more likely to develop SPC compared to non-irradiated cases (IRR=1.18, 95% CI: 1.14, 1.23). CONCLUSIONS: This is the first analysis of race-specific SPC risk in EC cases and it suggests differences between white and black cases. Although exploratory, these data provide important clues about the etiology of SPC in patients with EC. This analysis also highlights the need for careful monitoring following diagnosis and treatment of EC.
Authors: Albert G Crawford; Christine Cote; Joseph Couto; Mehmet Daskiran; Candace Gunnarsson; Kara Haas; Sara Haas; Somesh C Nigam; Rob Schuette Journal: Popul Health Manag Date: 2010-06 Impact factor: 2.459
Authors: Terri Madison; David Schottenfeld; Sherman A James; Ann G Schwartz; Stephen B Gruber Journal: Am J Public Health Date: 2004-12 Impact factor: 9.308
Authors: M F Kohler; P Carney; R Dodge; J T Soper; D L Clarke-Pearson; J R Marks; A Berchuck Journal: Am J Obstet Gynecol Date: 1996-11 Impact factor: 8.661
Authors: Laura J Havrilesky; Angeles Alvarez Secord; David M O'Malley; Gloria Broadwater; Victoria Bae-Jump; David E Cohn; Paola A Gehrig Journal: Gynecol Oncol Date: 2009-05-15 Impact factor: 5.482
Authors: Stefanie M Ueda; Daniel S Kapp; Michael K Cheung; Jacob Y Shin; Kathryn Osann; Amreen Husain; Nelson N Teng; Jonathan S Berek; John K Chan Journal: Am J Obstet Gynecol Date: 2008-02 Impact factor: 8.661
Authors: Sanjeev Kumar; Jay P Shah; Christopher S Bryant; Awoniyi O Awonuga; Anthony N Imudia; Julie J Ruterbusch; Michele L Cote; Rouba Ali-Fehmi; Robert T Morris; John M Malone Journal: Gynecol Oncol Date: 2009-02-26 Impact factor: 5.482
Authors: Nicholas W Bateman; Christopher M Tarney; Tamara S Abulez; Brian L Hood; Kelly A Conrads; Ming Zhou; Anthony R Soltis; Pang-Ning Teng; Amanda Jackson; Chunqiao Tian; Clifton L Dalgard; Matthew D Wilkerson; Michael D Kessler; Zachary Goecker; Jeremy Loffredo; Craig D Shriver; Hai Hu; Michele Cote; Glendon J Parker; James Segars; Ayman Al-Hendy; John I Risinger; Neil T Phippen; Yovanni Casablanca; Kathleen M Darcy; G Larry Maxwell; Thomas P Conrads; Timothy D O'Connor Journal: iScience Date: 2021-12-23
Authors: Faina Linkov; Jonathan C Silverstein; Michael Davis; Brenda Crocker; Degan Hao; Althea Schneider; Melissa Schwenk; Sharon Winters; Joyce Zelnis; Adrian V Lee; Michael J Becich Journal: J Pathol Inform Date: 2018-12-24